KBC Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-45,900
| Closed | -$237K | – | 1282 |
|
|
2021
Q3 | $237K | Sell |
45,900
-5,900
| -11% | -$30.5K | ﹤0.01% | 1034 |
|
|
2021
Q2 | $220K | Buy |
51,800
+38,000
| +275% | +$161K | ﹤0.01% | 1159 |
|
|
2021
Q1 | $74K | Buy |
13,800
+6,000
| +77% | +$32.2K | ﹤0.01% | 1262 |
|
|
2020
Q4 | $231K | Hold |
7,800
| – | – | ﹤0.01% | 1247 |
|
|
2020
Q3 | $62K | Sell |
7,800
-4,000
| -34% | -$31.8K | ﹤0.01% | 1200 |
|
|
2020
Q2 | $118K | Buy |
11,800
+5,900
| +100% | +$59K | ﹤0.01% | 1201 |
|
|
2020
Q1 | $16K | Hold |
5,900
| – | – | ﹤0.01% | 1260 |
|
|
2019
Q4 | $7K | Buy |
5,900
+5,730
| +3,371% | +$6.8K | ﹤0.01% | 1481 |
|
|
2019
Q3 | $0 | Sell |
170
-1,730
| -91% | – | ﹤0.01% | 1480 |
|
|
2019
Q2 | $8K | Hold |
1,900
| – | – | ﹤0.01% | 1441 |
|
|
2019
Q1 | $8K | Buy |
1,900
+950
| +100% | +$4K | ﹤0.01% | 1399 |
|
|
2018
Q4 | $5K | Hold |
950
| – | – | ﹤0.01% | 1302 |
|
|
2018
Q3 | $13K | Hold |
950
| – | – | ﹤0.01% | 1379 |
|
|
2018
Q2 | $11K | Hold |
950
| – | – | ﹤0.01% | 1279 |
|
|
2018
Q1 | $11K | Hold |
950
| – | – | ﹤0.01% | 1260 |
|
|
2017
Q4 | $6K | Buy |
+950
| New | +$6K | ﹤0.01% | 1254 |
|